Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Glatiramer acetate and interferon-beta throughout gestation and postpartum in women with multiple sclerosis.
Increased CD8+ T Cell Response to Epstein-Barr Virus Lytic Antigens in the Active Phase of Multiple Sclerosis.
Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial.
Differential effects of fingolimod on B-cell populations in multiple sclerosis.
American Society for Cell Biology Annual Meeting
Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage.
A Study to Evaluate 2 Doses Of Oral Administration Of Laquinimod Compared to Interferon ß-1a Administered by Injection in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) (LIBRETTO)
Genzyme's Lemtrada resubmission accepted for review by FDA
Balance impairment in people with multiple sclerosis: Preliminary evidence for the Balance Evaluation Systems Test.
Interferon beta 1b following natalizumab discontinuation: one year, randomized, prospective, pilot trial.
Peripheral and Central Nervous System Drugs Advisory Committee Meeting: Alemtuzumab (BLA 103948\5139) Background Package
European Congress of Immunology 2012
The INCAT disability score: A critical analysis of its measurement properties.
GeNeuro and Servier sign partnership to develop first medicine addressing a causal factor of multiple sclerosis
Disrupted balance of T cells under natalizumab treatment in multiple sclerosis.
Rescue Therapy Using Rituximab for Multiple Sclerosis.
Fatigue, depression and sleep disturbances in Iranian patients with multiple sclerosis.
Risk factors for rare diseases can be risky to define: PML and natalizumab.
The Vitamin D to Ameliorate Multiple Sclerosis (VIDAMS) trial: study design for a multicenter, randomized, double-blind controlled trial of vitamin D in multiple sclerosis.
Effects of rituximab on lymphocytes in multiple sclerosis and neuromyelitis optica.
The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service.
Mitochondrial approaches for neuroprotection.
Multigate Quality Doppler Profiles and Morphological/Hemodynamic Alterations in Multiple Sclerosis Patients.
Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1.
Increase in NF-κB-sensitive miRNA-146a and miRNA-155 in multiple sclerosis (MS) and pro-inflammatory neurodegeneration.

Pages